OBSERVE: Biomarkers in Individuals at Risk for Prion Disease
NCT05124392
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
We are doing this research to identify biomarkers in individuals who are at-risk for familial prion disease. We hope to use these biomarkers to predict timing of disease onset in pre-symptomatic individuals and to guide the direction of future clinical trials.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- CJD (Creutzfeldt Jakob Disease)
- Prion Diseases
- GSS
- FFI
- Familial Fatal Insomnia
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Massachusetts General Hospital
- Last updated on ClinicalTrials.gov
- August 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 1
- Alzheimer's Clinical and Translational Research Unit · Charlestown, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.